Background Psychological stress has long been linked with the exacerbation/onset of psoriasis. Objectives To determine if antecedent psychological stress is associated with the exacerbation/onset of psoriasis. Methods A search of the PubMed, PsycINFO, Cochrane library and ClinicalTrials.gov databases was performed. Surveys evaluating beliefs about stress reactivity were analysed separately. Suitable studies were meta-analysed. Results Thirty-nine studies (32 537 patients) were included: 19 surveys, seven cross-sectional studies, 12 case-control studies and one cohort study. Forty-six per cent of patients believed their disease was stress reactive and 54% recalled preceding stressful events. Case-control studies evaluating stressful events rates prior to the exacerbation (n = 6) or onset (n = 6) of psoriasis varied in time lag to recollection (≤ 9 months to ≥ 5 years). Pooling five studies evaluating stressful events preceding onset of psoriasis gave an odds ratio (OR) of 3Á4 [95% confidence interval (CI) 1Á8-6Á4; I 2 = 87%]; the only study evaluating a documented
stress disorder diagnosis reported similar rates between patients and controls (OR 1Á2, 95% CI 0Á8-1Á8). Four studies evaluating stressful events prior to psoriasis exacerbation reported comparable rates with controls, whereas two found more frequent/severe preceding events among patients with psoriasis. A small prospective cohort study reported a modest association between stress levels and exacerbation of psoriasis (r = 0Á28, P < 0Á05). Conclusions The association between preceding stress and exacerbation/onset of psoriasis is based primarily on retrospective studies with many limitations. No convincing evidence exists that preceding stress is strongly associated with exacerbation/onset of psoriasis.
What's already known about this topic?
• It is common knowledge among patients with psoriasis and their physicians that psychological stress aggravates psoriasis.
• Numerous observational studies have suggested a link between preceding psychological stress and exacerbation and onset of psoriasis.
What does this study add?
• A review of the current literature revealed that the association between preceding stress and psoriasis is built almost exclusively on retrospective studies with many limitations. To date, no convincing evidence exists that stress is strongly associated with psoriasis exacerbation and onset.
• This finding is psychologically beneficial for patients and has occupational and therapeutic implications.
Psoriasis is a chronic inflammatory skin disorder with a complex immune-mediated pathophysiology affecting between 0Á9% and 8Á5% of the general population. 1 Descriptions of a relationship between psychological stress and psoriasis date back centuries. In a case history of a patient with outbreaks of psoriasis written > 1200 years ago, a Persian physician suggested that severe interpersonal conflicts may have been a contributory factor. 2 Psychological stress occurs when an individual perceives the environmental demands tax or exceed their adaptive capacity. 3 The operationalization of stress and the physiological mechanisms mediating the interplay of stress and psoriasis are complex. 4 Early survey-based studies evaluated patients' beliefs on the role of emotional stress on the exacerbation and onset of psoriasis. 5 In the 1960s, the life event paradigm gained impetus with the development of life event inventories that included positive (e.g. marriage) or negative (e.g. the death of a spouse) events, which were used as indicators of external stressors. 6 Later, life event checklists evolved to expand the range of major events evaluated. A major milestone was the development of structured life event interviews, which allowed the researcher to gain insight into the context and timing of events. Although many observational studies utilizing the aforementioned methodologies pointed to an association between antecedent stress and the exacerbation and onset of psoriasis, their results should be interpreted with caution, given their retrospective nature, which is prone to multiple biases. Notably, recall bias is a major threat to studies' internal validity, given that many patients with psoriasis preconceive stress as a risk factor. 7 Several physiological mechanisms have been proposed to explain the relationship between stress and psoriasis. 8, 9 Studies exploring the 'brain-skin connection' have revealed that the skin is both a prominent target organ and a factory for neuroendocrine, neurotransmitter and neuropeptide signals, which profoundly affect skin biology. Thus, upon perception of stress, the skin may respond by releasing inflammatory cytokines. In turn, this may lead to mast cell activation, which promotes immune dysregulation and neurogenic inflammation. 8 Despite widespread belief of the association between preceding stress and the exacerbation and onset of psoriasis, no systematic review has been conducted to date. Given the important clinical and occupational implications of this topic the aim of this systematic review and meta-analysis is to provide a comprehensive overview of the literature linking antecedent psychological stress with exacerbation and onset of psoriasis. 10 
Materials and methods
The systematic review and meta-analysis were conducted and reported according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement and registered with the PROSPERO international prospective register (CRD42016044007).
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Search strategy
A comprehensive database search was performed independently using PubMed, the ongoing trials registry/database of the U.S. National Institutes of Health (www.clinicaltrials.gov); Cochrane Central Register of Controlled Trials; Cochrane Database of Systematic Reviews; PsycINFO; and the reference lists of included articles. The following search terms were used: ["Psoriasis" (medical subject heading; MeSH) OR psoriasis) AND ["stress, psychological" (MeSH) OR Stress OR stressor OR stressors OR psychological OR psychic OR life events]. We included only studies published in or translated into English from inception to May 2017. Reference lists from included studies were manually scanned to identify any additional results. Authors were contacted for missing data and clarifications. Any disagreement was resolved by discussion with a third author (L.P).
Eligibility criteria
Studies that met the following criteria were included: (i) relevance -original study of any design analysing the association between antecedent psychological stress (prospectively or by patients' recollection) and onset or clinical exacerbation of psoriasis; (ii) participants -patients of all ages of either sex with a clinical diagnosis of psoriasis. Controls in case-control studies were healthy participants or participants with minor skin disorders believed to be unrelated to stress (e.g. naevi and fungal infections). Permissive criteria for the progression of psoriasis was allowed, not contingent on the use of validated scales [e.g. Psoriasis Area and Severity Index (PASI)], including self-description of an exacerbation.
We excluded: (i) studies with sample sizes < 10; (ii) studies assessing the effects of stress on treatment effectiveness (e.g. psoriasis clearance); and (iii) nonplaque subtypes of psoriasis (studies were included if > 55% of patients had plaquetype psoriasis).
Study selection and data extraction
Two reviewers (I.S. and O.R.) independently screened the titles and abstracts of all retrieved articles followed by the full text of articles considered to be potentially eligible for inclusion. Subsequently, data were extracted into a predefined electronic extraction form, which included the following: (i) study characteristics (country, year, design, setting); (ii) participants' characteristics (mean age, sex, number of cases and controls, control definition); (iii) exposure and disease characteristics, such as screening tools for stress, exposure characteristics, disease definition, exposure-disease interval, outcome recollection interval and effect estimates. Psychological stress was assessed using different methods, including self-reported diagnosis and various validated scales evaluating specific life events, such as the Social Readjustment Rating Scale.
Two reviewers (I.S. and O.R.) independently assessed the risk of bias in the included studies with the Newcastle-Ottawa Scale (NOS). 12 A modified NOS was used for cross-sectional studies (Appendix S1; see Supporting Information). Grading was categorized as follows: low < 4; moderate 4-6; high > 6. 13 Any disagreement was resolved by discussion with a third author (L.P).
Data analysis
All studies were classified according to their method of evaluating the relationship between stress and psoriasis as follows: (i) cross-sectional, (ii) case-control or (iii) cohort. Surveys that evaluated patients' beliefs about stress reactivity were analysed separately. Patients' beliefs were operationalized by questioning patients on whether stress was a trigger of psoriasis or connected to psoriasis flare-ups. Data were combined at the aggregate level and presented using descriptive statistics. Patients' beliefs regarding stress reactivity were analysed by year of publication, using linear regression. The result is presented as a correlation coefficient (r) with the statistical significance set at P < 0Á05. Publication bias was not assessed owing to the small number of studies included.
14 For quantitative analysis, odds ratios (ORs) for stressful events prior to the onset of psoriasis were calculated with 95% confidence intervals (CIs). ORs were pooled using statistical software (Comprehensive Meta-Analysis, Version 3Á0). Analyses were performed using the random-effects model of DerSimonian and Lard because we expected considerable heterogeneity across stress screening tools. Heterogeneity was assessed by visually examining the forest plot for nonoverlapping CIs using the v 2 -test, with P < 0Á1 indicating statistical significance and I 2 > 50% indicating substantial heterogeneity.
Results
Our initial search yielded 1526 results ( Fig. 1 ). We excluded 57 duplicate studies. After examining the titles and abstracts of the retrieved studies, 64 were selected based on the eligibility criteria. After reviewing the full-length articles, 25 were excluded for the following reasons: lack of a temporal relationship between stress and psoriasis (n = 7), duplicates (n = 8), nonplaque-type psoriasis (n = 4), evaluation of stress on treatment effectiveness (n = 3), insufficient information (n = 2) and sample size < 10 (n = 1).
Characteristics of the included studies
Thirty-nine studies, evaluating 32 537 patients, fulfilled the eligibility criteria (19 surveys, 7,15-32 seven cross-sectional studies, [33] [34] [35] [36] [37] [38] [39] 12 case-control studies, [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] one cohort study 52 ).
The characteristics of the case-control and cohort studies are presented in Table 1 ; the characteristics of the included surveys and cross-sectional studies are presented in Tables S1 and  S2 (see Supporting Information) . Studies were published between 1964 and 2015. The studies were conducted in Europe (n = 26), Asia (n = 8), the U.S.A. (n = 4) and Africa (n = 1). Thirty studies were conducted in an outpatient setting and nine in an inpatient setting. Participants' mean age ranged from 12 to 52 years. Studies used heterogeneous methodologies: surveys evaluated patients' beliefs regarding stress reactivity; cross-sectional and case-control studies evaluated the association between preceding stressful life events and exacerbation and onset of psoriasis; and one cohort study prospectively evaluated the association between daily stress levels and exacerbation of psoriasis. Disease definition varied (excluding surveys): exacerbation (n = 10), psoriasis onset (n = 9), mixed definition (n = 1). Only six studies reported on the nature of events, four of which were related to family issues. Stress-psoriasis time interval varied significantly among the included studies: surveys and cross-sectional studies mostly failed to report specific time frames; case-control studies reported the interval to be within 12 months; a cohort study reported a pre-emptive interval of 4 weeks. Only nine casecontrol studies reported an outcome recollection time lag, which varied substantially: ≤ 6 months (n = 5); within 9 months to more than 5 years (n = 4). The quality of the studies based on the NOS is reported in Tables S3 and S4 (see Supporting Information) and is summarized in Table 1 . Seven case-control studies were designated as high quality, nine studies were of moderate quality (three cross-sectional, five case-control, one cohort) and four crosssectional studies were designated as low quality. Points were most often lost on the method of ascertaining exposure to stress and on comparability. Overall, 12 studies ascertained exposure to stress based on nonvalidated scales, including questionnaires/clinical interviews (n = 7) and via validated scales, yet were not blinded to case-control status (n = 5). Only three cross-sectional, four case-control and one cohort study adequately ascertained exposure to stress. Results were not affected by a study's quality.
Patients' beliefs of reactivity to stress
Nineteen surveys, evaluating a total of 26 099 participants, evaluated patients' beliefs regarding stress and exacerbation and onset of psoriasis. Forty-six per cent (range 27-88) of patients believed their disease was reactive to stress. Using a linear regression model, we calculated a correlation coefficient of 0Á44 (P < 0Á05) between year of publication and belief prevalence (Fig. 2) .
Preceding stressful events and exacerbation and onset of psoriasis in cross-sectional studies Seven studies with 1275 patients and no control group were included. Based on heterogeneous, mostly nonvalidated screening tools, including psychiatric interviews, questionnaires and life events scales, 54% of participants recalled stressful events preceding exacerbation and onset of psoriasis. One study reported a correlation coefficient of 0Á28 (P < 0Á0001) between stressful events and exacerbation of psoriasis. Preceding stressful events and psoriasis onset in case-control studies
Six studies with 4744 patients with psoriasis and 10 817 controls were included. Five studies provided rates of preceding stressful event and stress disorder prior to onset of psoriasis, which were included in a meta-analysis (Fig. 3 ). Rates were significantly higher among patients with psoriasis compared with controls (pooled OR 3Á4, 95% CI 1Á8-6Á4; P < 0Á001, I 2 = 87%); [41] [42] [43] [44] [45] however, the only study reporting documented stress disorder rates found no difference between patients with psoriasis and controls (OR 1Á2, 95% CI 0Á8-1Á8). 45 The substantial heterogeneity may be attributable to nonvalidated assessment of stress and variability of time lag to recollection (five studies provided data, ≤ 9 months to ≥ 5 years). One additional study, evaluating patients > 5 years after disease onset, reported more severe events among patients with psoriasis vs. controls.
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Preceding stressful events and exacerbation of psoriasis in case-control studies
Six case-control studies with 357 patients with psoriasis and 595 controls without psoriasis were included. Four studies evaluating patients within 6 months of disease exacerbation found comparable preceding stressful events rates between patients with psoriasis and controls. 40, 47, 48, 50 Two studies failing to report on time lag to recollection found higher rates (OR 5Á8, 95% CI 3-11) and more severe events among the patients with psoriasis than in controls. 46, 49 Association between daily stress and exacerbation of psoriasis in a cohort study
One prospective cohort study evaluated 62 patients with mild psoriasis. 52 Patients were followed for 6 months with monthly clinical evaluation by a dermatologist, including assessment of daily stress levels using a validated scale. A modest, albeit statistically significant, correlation coefficient of 0Á28 (P < 0Á05) was found between stress levels and exacerbation of psoriasis 4 weeks later. An absolute PASI worsening of 1 was reported between minimum and maximum levels of stress.
Discussion
The results of this comprehensive systematic review indicate that there is no high-quality evidence to support the notion that preceding psychological stress is strongly associated with exacerbation and onset of psoriasis. As stress is a general concept with psychological, behavioural and biological determinants, 53 we pre-emptively decided to focus on the broad definition of psychological stress. Accordingly, studies' descriptions of stress ranged from a general, nonspecific type to definitive stressful events. In all, we included 39 heterogeneous studies published in the last 50 years from across the globe with conflicting findings and heterogeneous methodologies. Nineteen studies surveyed 26 099 patients with psoriasis regarding their beliefs in the role of stress in their disease.
7,15-32 On average, 46% of patients believed their disease was reactive to stress. Berg et al. noted that the percentage of patients believing psoriasis was stress-related was low in studies prior to 1990 but increased thereafter. 54 To further investigate this finding, we performed a linear regression analysis confirming a growing positive trend over time (Fig. 2) . The increase may be at least partly attributable to greater patient accessibility to medical services, which commonly accept stress as a well-established risk factor in psoriasis. 55 Additionally, five cross-sectional studies revealed that, on average, 54% of patients could recall major life events preceding the exacerbation and onset of psoriasis. [34] [35] [36] [37] [38] Patients' perceptions are of limited validity in proving the association between preceding stress and exacerbation and onset of psoriasis, given that many patients describe stress to be a consequence of psoriasis. 56 Additionally, dermatologistsmany of whom believe that stress plays a significant role in psoriasis 57 -may inadvertently contribute to the tendency of their patients to associate stress with psoriasis by questioning or informing them about the aggravating role of stress. Overall, as all cross-sectional studies lacked control groups and failed to report on time lag to event recollection, they add little value in supporting the association between preceding stress and exacerbation and onset of psoriasis. Case-control studies evaluated the occurrence of stressful events preceding exacerbation (n = 6) and onset (n = 6) of psoriasis vs. controls without psoriasis, yielding inconsistent results. Accordingly, the pooled ORs of five studies evaluating stressful events preceding the onset of psoriasis, [41] [42] [43] [44] [45] with considerable heterogeneity and under-reporting of time lag to recollection, found higher rates among patients with psoriasis vs. controls (OR 3Á4, 95% CI 1Á8-6Á4; I 2 = 87%).
Likewise, two studies failing to report the time lag to recollection found more frequent (OR 5Á8, 95% CI 3-11) and severe life events among patients with psoriasis prior to disease exacerbation. 46, 49 In contrast, the only study that was not based on patient recollection reported comparable stress disorder rates (OR 1Á2, 95% CI 0Á8-1Á8), 45 and four studies evaluating patients with a recent exacerbation of psoriasis (≤ 6 months) reported comparable life events rates between patients and controls, 40, 47, 48, 50 highlighting the importance of adequate reporting of the time lag to recollection in future studies. The significant amount of heterogeneity can also be attributed to nonvalidated measurement of stress. For instance, in one study, patients were first questioned about their belief concerning the stress-psoriasis relationship before undergoing life events evaluation. 41 This might have amplified patients' recollection of events, culminating in a significant OR of 12 (95% CI 5-27; P < 0Á001). In all, the weight of evidence of case-control studies increases toward a limited association between antecedent stress and onset and exacerbation of psoriasis. Nonetheless, as studies evaluated primarily major life events while neglecting daily and chronic stressors, unequivocal conclusions cannot be drawn. Because cohort studies measure events in a chronological order and can make a distinction between cause and effect, they may be the best study design for the topic of interest. 58 Unfortunately, only one cohort study with 62 patients was retrieved, indicating that antecedent stress has only a modest association with exacerbation of onset and exacerbation (r = 0Á28; P < 0Á05), thus supporting case-control studies with a higher quality of evidence. 52 Similarly, two small prospective studies not meeting our eligibility criteria found no, or only a modest, association (r = 0Á31; P < 0Á01) between antecedent stress levels and subsequent exacerbation of onset and exacerbation. 54, 59 Finally, the mechanisms underlying the interplay between stress and psoriasis are not fully understood, and a study of the interaction between psychology and the nervous and immune systems is in order. Classically, neurochemical and hormonal mechanisms, including activation of the innate immune system, have been proposed to explain the pathological effect of stress on the exacerbation and onset of psoriasis. 60 Yet, more recent studies have focused on the potential adaptive function of stress, including stress-induced immunosuppression. 9 The net outcome of these contrasting effects is yet to be determined. Our study has some methodological limitations. Firstly, it is possible that pertinent studies were missed because the search was restricted to articles published in English. 61 Secondly, we primarily evaluated plaque-type psoriasis, yet it is possible that certain subtypes are more strongly associated with stress. Thirdly, several studies have shown that psychological stress may reduce the efficacy of psoriasis treatment, 62 whereas simple stress-alleviating interventions may be advantageous. 63, 64 As the effect of stress on treatment effectiveness was beyond the scope of this work, further research is recommended. The literature on the association between antecedent psychological stress and exacerbation and onset of psoriasis is built almost exclusively on retrospective studies with many limitations. Although surveys and cross-sectional studies have shown that most patients with psoriasis believe they are reactive to psychological stress and can recall major events preceding disease, this cannot be interpreted as evidence of a causal relation. Case-control studies assessing the occurrence of major events have yielded inconsistent results with significant heterogeneity and under-reporting of the time lag to recollection. Given that only one small prospective cohort study was retrieved, concluding stress levels were only modestly associated with exacerbation of psoriasis, no convincing evidence exists that antecedent stress is strongly associated with exacerbation and onset of psoriasis. As previous studies have found that a clear relationship could only be established under extreme states of stress, further prospective studies evaluating the full spectrum of psychological stress are needed. 31, 61 Our study has major implications in several clinical spheres. Although a recent systematic review set out to assess the risk for suicidal ideation/suicidality among patients with psoriasis concluded no association existed, 13 previous studies have shown that the mere belief that stress causes psoriasis is associated with higher levels of anxiety, stress and depression. 20, 65 Thus, our study may have psychological significance for patients with psoriasis. From the occupational perspective, on the basis of personal experience and beliefs, stress is commonly regarded as a well-established trigger of psoriasis. Consequently, our conclusion has implications for disability and pension entitlement, 10 and highlights the need for evidence-based consensus standards. This study can guide the design of future studies in terms of validated stress measurement, reporting the time lag to recollection and paying attention to daily/chronic stressors. Finally, from a therapeutic aspect, patients with psoriasis should be carefully assessed for known trigger factors before attributing disease exacerbation and onset to psychological stress.
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